GL1X · GenesisL1 explorer

MolNFT v1 · #70436 · protein

Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 6-fluoro-N-[2-hydroxy-1(S)-benzamides

3LKH · RNA-directed RNA polymerase: “Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel…”. X-ray diffraction, 1 ligand (LT6), 20 pockets (best druggability 0.81). MolNFT v1 #70436 on GenesisL1: 3D…

PDB
3LKH
Type
protein
Length
1,112 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
RNA-directed RNA polymerase
EC
2.7.7.48
UniProt
O92972
Ligands
LT6
Pockets
20 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 49% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARNA-directed RNA polymerase (EC 2.7.7.48)protein55449% helix, 16% strandO92972
BRNA-directed RNA polymerase (EC 2.7.7.48)protein55848% helix, 15% strandO92972

Ligands and binding sites

  • LT6 · 2-(2-{[(1S)-1-benzyl-2-hydroxyethyl]amino}-2-oxoethoxy)-N-butyl-6-fluoro-N-methylbenzamide · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12110.810.9526LT6
22200.810.9424LT6
39650.790.8185empty
49280.790.8178empty
51700.580.8121empty

Interfaces

1 interface between chains.

  • A–B · 988 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide (disulfide).

Compared structures

  • 3LKH · Inhibitors of Hepatitis C Virus Polymerase: Synthesis and Characterization of Novel… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.